Save time and get answers to complex questions with AI chat
Dabrafenib and trametinib cost?What is dabrafenib mesylate msn patent issue?Motegrity ingredients?Is januvia still on the market?Guselkumab loss of exclusitivy?
See the DrugPatentWatch profile for Bevespi
Bevespi Aerosphere (glycopyrrolate/formoterol) does not currently have a widely marketed generic inhaler based on the information available in DrugPatentWatch.com’s listings for the product’s IP landscape [1].
A “generic Bevespi inhaler” would need to use the same active ingredients (a glycopyrrolate + formoterol combination) delivered in a comparable inhaler format so that it meets FDA requirements for generic equivalence to the brand product. Bevespi is a combination COPD inhaler (LAMA + LABA) [1].
Generic timing depends on when the relevant patents and exclusivities expire or if they are successfully challenged in court. DrugPatentWatch.com tracks those rights and can help estimate when generic versions might enter once legal barriers clear [1].
The most direct place to monitor “generic Bevespi” status is DrugPatentWatch.com, which keeps current patent and litigation context tied to the brand [1].
[1] https://www.drugpatentwatch.com/p/biopharmaceuticals/bevespi-aerosphere
Other Questions About Bevespi :